Moderna CEO says data for Omicron-specific shot likely available in March

Summary by Ground News
Moderna Inc's vaccine candidate against the Omicron coronavirus variant will enter clinical development in the next few weeks. The company expects to be able to share data with regulators around March, CEO Stephane Bancel said on Monday. Many countries are already offering a third dose of a COVID-19 vaccine to their citizens.
4 months ago·Washington, United States

News Articles

Times of India

Moderna CEO says data for Omicron-specific shot likely available in March

"The vaccine is being finished, it should be in the clinic in coming weeks. We are hoping in the March timeframe to be able to have data to share with regulators to figure out next steps," Bancel said at the World Economic Forum's virtual Davos Agenda conference.

4 months ago·Mumbai, India
Read Full Article
Reuters

Moderna CEO says data for Omicron-specific shot likely available in March

Moderna Inc's vaccine candidate against the Omicron coronavirus variant will enter clinical development in the next few weeks and the company expects to be able to share data with regulators around March, CEO Stephane Bancel said on Monday.

4 months ago·United Kingdom
Read Full Article
CTV News

Moderna CEO says data for Omicron-specific shot likely available in March

Moderna Inc's vaccine candidate against the Omicron coronavirus variant will enter clinical development in the next few weeks and the company expects to be able to share data with regulators around March, CEO Stephane Bancel said on Monday.

4 months ago·Toronto, Canada
Read Full Article
Financial Post

Moderna CEO says data for Omicron-specific shot likely available in March

Moderna Inc’s vaccine candidate against the Omicron coronavirus variant will enter clinical development in the next few weeks and the company expects to be…

4 months ago·Canada
Read Full Article
France24

Covid-flu joint booster jab possible late 2023: Moderna

Moderna aims to roll out a combined Covid-flu-RSV booster vaccine in late 2023, the US pharmaceutical firm said Monday, hoping a joint jab would encourage people to get an annual shot.

4 months ago·France
Read Full Article
India Today

Moderna CEO says data for Omicron-specific shot likely available in March

Moderna is also developing a single vaccine that combines a booster dose against COVID-19 with its experimental flu shot.

4 months ago·India
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

64% of the sources lean Right
Reuters
CTV News
France24
Live Mint
Times of India
Financial Post
India Today
Business Live
Regina Leader-Post
Colorado Springs Gazette
+2
C 36%
R 64%
Untracked bias
See less detail